Previous close | 1.7430 |
Open | 1.7290 |
Bid | 1.7700 x 0 |
Ask | 1.8050 x 0 |
Day's range | 1.7290 - 1.8270 |
52-week range | 0.9730 - 4.4380 |
Volume | |
Avg. volume | 5,365 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2024 Earnings Call Transcript May 8, 2024 CytomX Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.1669, expectations were $-0.03. CytomX Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
Q1 2024 CytomX Therapeutics Inc Earnings Call
Explore key financial outcomes and clinical advancements as CytomX Therapeutics Inc (CTMX) navigates through Q1 2024 with robust partnerships and innovative cancer treatments.